Publications by authors named "Massimo Parlani"

Claim this Profile
B
Benzofused hydroxamic acids: useful fragments for the preparation of histone deacetylase inhibitors. Part 2: 7-fluorobenzothiophenes and benzofurans.
Elena Marastoni, Sandra Bartoli, Marco Berettoni, Amalia Cipollone, Alessandro Ettorre, Massimo Parlani

Bioorg Med Chem Lett· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzofused hydroxamic acids: useful fragments for the preparation of histone deacetylase inhibitors. Part 1: hit identification.
Elena Marastoni, Sandra Bartoli, Marco Berettoni, Amalia Cipollone, Alessandro Ettorre, Massimo Parlani

Bioorg Med Chem Lett· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SAHA/Vorinostat induces the expression of the CD137 receptor/ligand system and enhances apoptosis mediated by soluble CD137 receptor in a human breast cancer cell line.
Daniela Bellarosa, Alessandro Bressan, Mario Bigioni, Massimo Parlani, Carlo Alberto Maggi

Int J Oncol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Set-up of a new series of HDAC inhibitors: the 5,11-dihydrodibenzo[b,e]azepin-6-ones as privileged structures.
Mario Bigioni, Alessandro Ettorre, Patrizia Felicetti, Sandro Mauro, Cristina Rossi, Massimo Parlani

Bioorg Med Chem Lett· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-N-Hydroxy-4-[1-(sulfonyl)piperidin-4-yl]-butyramides as HDAC inhibitors.
Cristina Rossi, Christopher I Fincham, Piero D'Andrea, Marina Porcelloni, Alessandro Ettorre, Massimo Parlani

Bioorg Med Chem Lett· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined antihypertensive and cardioprotective effects of nebivolol and hydrochlorothiazide in spontaneous hypertensive rats.
Giuseppe Sacco, Stefano Evangelista, Stefano Manzini, Massimo Parlani, Mario Bigioni

Future Cardiol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alkyl piperidine and piperazine hydroxamic acids as HDAC inhibitors.
Cristina Rossi, Marina Porcelloni, Piero D'Andrea, Christopher I Fincham, Alessandro Ettorre, Massimo Parlani

Bioorg Med Chem Lett· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiproliferative and differentiating activities of a novel series of histone deacetylase inhibitors.
Monica Binaschi, Andrea Boldetti, Maurizio Gianni, Carlo Alberto Maggi, Martina Gensini, Massimo Parlani

ACS Med Chem Lett· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity of delimotecan against human metastatic melanoma: pharmacokinetics and molecular determinants.
Mario Bigioni, Massimo Parlani, Alessandro Bressan, Daniela Bellarosa, Licia Rivoltini

Int J Cancer· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human and murine macrophages mediate activation of MEN 4901/T-0128: a new promising camptothecin analogue-polysaccharide conjugate.
Monica Binaschi, Massimo Parlani, Daniela Bellarosa, Mario Bigioni, Carmela Salvatore

Anticancer Drugs· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and characterization of biologically active human Fas ligand produced in CHO cells.
Sabrina Zappitelli, Laura D'Alatri, Allesandra Ciucci, Giuseppe Raucci, Angela Faiella, Massimo Parlani

Mol Biotechnol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis